Tower Research Capital (TRC)’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.75K | Buy |
|
|||||
|
2025
Q1 | $11.5K | Buy |
|
|||||
|
2024
Q4 | $7.33K | Buy |
|
|||||
|
2024
Q3 | $1.88K | Sell |
|
|||||
|
2024
Q2 | $14.9K | Buy |
|
|||||
|
2024
Q1 | $7.68K | Sell |
|
|||||
|
2023
Q4 | $9.84K | Buy |
|
|||||
|
2023
Q3 | $13.7K | Sell |
|
|||||
|
2023
Q2 | $29.7K | Buy |
|
|||||
|
2023
Q1 | $8K | Sell |
|
|||||
|
2022
Q4 | $39K | Buy |
|
|||||
|
2022
Q3 | $23K | Sell |
|
|||||
|
2022
Q2 | $26K | Buy |
|
|||||
|
2022
Q1 | $37K | Buy |
|
|||||
|
2021
Q4 | $40K | Buy |
|
|||||
|
2021
Q3 | $63K | Buy |
|
|||||
|
2021
Q2 | $43K | Buy |
|
|||||
|
2021
Q1 | $38K | Sell |
|
|||||
|
2020
Q4 | $223K | Buy |
|
|||||
|
2020
Q3 | $101K | Buy |
|